CHINOMSO EZENWATA: Open Payments
NPI 1851785828 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 6 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $183 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 4 | $152 |
| Gilead Sciences, Inc. | 1 | $130 |
| Janssen Pharmaceuticals, Inc | 1 | $91 |
Products named: Epclusa, INVEGA SUSTENNA.
Industry payments across NV — which companies pay providers there.
